Thema: VXM101 plus Avelumab Studie (T-Zell-Immuntherapie)
VXM101 plus Avelumab Studie (T-Zell-Immuntherapie)
mrg
20.11.2019 20:40:52
Feenmarie
15.03.2021 09:28:38
tom9845
23.03.2021 07:30:18
Annemon
02.04.2021 14:01:42